NordivVMS

Metabolomix+

Urine

21 ±5 days Days

Indications

Fatigue or low energy: Tiredness or reduced stamina that may relate to mitochondrial dysfunction or nutrient insufficiency.
Mood and cognitive health: Low mood, anxiety, poor focus or memory changes possibly linked to neurotransmitter or amino acid metabolism.
Chronic stress: Ongoing stress or poor stress resilience that may influence adrenal function, energy production or nutrient demand.
Inflammation and oxidative stress: Joint discomfort, tissue irritation or signs of oxidative imbalance that may reflect antioxidant depletion.
Digestive function: Bloating, altered bowel habits or signs of malabsorption that may be associated with dysbiosis or nutrient absorption issues.
Cardiometabolic health: Weight gain, blood sugar imbalance or early cardiovascular changes potentially linked to fatty acid or organic acid markers.
Nutrient status: Assessment of functional need for antioxidants, B-vitamins, amino acids and minerals that support metabolic pathways.
Metabolic function: Exploration of altered organic acid, amino acid or fatty acid patterns in complex presentations affecting energy, cognition or weight regulation.

Overview

Metabolomix+ integrates multiple nutritional profiles to deliver a detailed overview of key organic acids, amino acids and oxidative stress markers. This comprehensive evaluation covers vital biochemical pathways, presenting insights into nutrient status, energy metabolism and detoxification processes. The broad scope supports an understanding of nutritional balance and metabolic function that can contribute to personal well-being.

The analysis encompasses aspects such as mitochondrial activity, oxidative stress levels, detoxification efficiency, neurotransmitter metabolism and markers related to gut microbiota balance. Optional add-ons extend the profile to include fatty acid composition, urinary elements and vitamin D levels, enriching the insight into essential fats, minerals and nutrient cofactors. This flexible approach allows tailored exploration of nutritional and metabolic factors relevant to lifestyle and dietary habits.

Variations in organic acid, amino acid and fatty acid patterns can reflect general changes in energy, mood and metabolic status. Metabolomix+ offers a convenient, non-invasive method to better understand how nutrient levels and lifestyle may influence these biochemical pathways. This information can support personal nutrition planning focused on optimising metabolic health and overall wellness.

Metabolomix+ is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. Metabolomix+ is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.

Downloads

Collection instructions

Danish

English

Finnish

Hebrew

Sample Report

English

Research

Kaluzna-Czaplinska J. Noninvasive urinary organic acids test to assess biochemical and nutritional individuality in autistic children. Clin Biochem. 2011;44(8-9):686-691.
Broquist HP, Luhby AL. Detection and isolation of formiminoglutamic acid from urine in folic acid deficiency in humans. Proc Soc Exp Biol Med. 1959;100(2):349-354.
Sun A-l, Ni Y-h, Li X-b, et al. Urinary methylmalonic acid as an indicator of early vitamin B12 deficiency and its role in polyneuropathy in type 2 diabetes. J Diab Res. 2014;2014.
Kwok T, Cheng G, Lai W, Poon P, Woo J, Pang C. Use of fasting urinary methylmalonic acid to screen for metabolic vitamin B12 deficiency in older persons. Nutrition. 2004;20(9):764-768.
Brown R, Thornton MJ, Price J. The effect of vitamin supplementation on the urinary excretion of tryptophan metabolites by pregnant women. J Clin Invest. 1961;40(4):617-623.
Lykouras L, Markianos M, Hatzimanolis J, Malliaras D, Stefanis C. Association of biogenic amine metabolites with symptomatology in delusional (psychotic) and nondelusional depressed patients. Prog Neuro-Psychopharmacol Biol Psych. 1995;19(5):877-887.
Frankenhaeuser M, Lundberg U, Von Wright MR, Von Wright J, Sedvall G. Urinary monoamine metabolites as indices of mental stress in healthy males and females. Pharmacol Biochem Behav. 1986;24(6):1521-1525.
Mitochondrial Medicine Society's Committee on D, Haas RH, Parikh S, et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab. 2008;94(1):16-37.
Dimmock DP, Lawlor MW. Presentation and Diagnostic Evaluation of Mitochondrial Disease. Pediatr Clin North Am. 2017;64(1):161-171.
Wu H, Jiang K, Gu G, Wu Y, Yu S. [The relationship of occupational stress and the level of some hormone metabolites in urine]. Chin J Indust Hyg Occup Dis. 2014;32(2):83-86.
Jeon SW, Kim Y-K. Inflammation-induced depression: Its pathophysiology and therapeutic implications. J Neuroimmunol. 2017;313:92-98.
Rao TSS, Asha MR, Ramesh BN, Rao KSJ. Understanding nutrition, depression and mental illnesses. Indian J Psychiatry. 2008;50(2):77-82.
O'Connell BS. Select vitamins and minerals in the management of diabetes. Diabetes Spectr. 2001;14(3):133-148.
Harris WS. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res. 2007;55(3):217-223.
Spencer SJ, Korosi A, Layé S, Shukitt-Hale B, Barrientos RM. Food for thought: how nutrition impacts cognition and emotion. Sci Food. 2017;1(1):1-8.